ocular pharmacology and toxicology 2.ppt

55
Ocular pharmacology Ocular pharmacology and toxicology and toxicology Hatem Kalantan, MD Hatem Kalantan, MD Assistant Professor Assistant Professor Ophthalmology Dept. Ophthalmology Dept. College of Medicine College of Medicine King Saud University King Saud University

Upload: boombubble

Post on 11-Jan-2016

54 views

Category:

Documents


6 download

TRANSCRIPT

Page 1: Ocular pharmacology and toxicology 2.ppt

Ocular pharmacology Ocular pharmacology and toxicologyand toxicology

Hatem Kalantan, MDHatem Kalantan, MDAssistant ProfessorAssistant ProfessorOphthalmology Dept.Ophthalmology Dept.College of MedicineCollege of MedicineKing Saud UniversityKing Saud University

Page 2: Ocular pharmacology and toxicology 2.ppt

General General pharmacological pharmacological principlesprinciples

Page 3: Ocular pharmacology and toxicology 2.ppt

Pharmacodynamics Pharmacodynamics

It is the biological and therapeutic effect It is the biological and therapeutic effect of the drug of the drug (mechanism of action)(mechanism of action)

Most drugs act by binding to regulatory Most drugs act by binding to regulatory macromolecules, usually macromolecules, usually neurotransmitters or hormone receptors neurotransmitters or hormone receptors or enzymesor enzymes

If the drug is working at the receptor If the drug is working at the receptor level, it can be level, it can be agonist or antagonistagonist or antagonist

If the drug is working at the enzyme If the drug is working at the enzyme level, it can be level, it can be activator or inhibitoractivator or inhibitor

Page 4: Ocular pharmacology and toxicology 2.ppt

Pharmacokinetics Pharmacokinetics

It is the absorption, distribution, It is the absorption, distribution, metabolism, and excretion of the drugmetabolism, and excretion of the drug

A drug can be delivered to ocular tissue as:A drug can be delivered to ocular tissue as:– Locally:Locally:

Eye dropEye drop OintmentOintment Periocular injectionPeriocular injection Intraocular injectionIntraocular injection

– Systemically:Systemically: OrallyOrally IVIV

Page 5: Ocular pharmacology and toxicology 2.ppt

Factors influencing local Factors influencing local drug penetration into drug penetration into ocular tissueocular tissue Drug concentration and solubility:Drug concentration and solubility: the higher the higher

the concentration the better the penetration the concentration the better the penetration e.g pilocarpine 1-4% but e.g pilocarpine 1-4% but limited bylimited by reflex reflex tearingtearing

Viscosity:Viscosity: addition of methylcellulose and addition of methylcellulose and polyvinyl alcohol increases drug penetration polyvinyl alcohol increases drug penetration by by increasing the contact timeincreasing the contact time with the with the cornea and cornea and altering corneal epitheliumaltering corneal epithelium

Lipid solubility:Lipid solubility: because of the lipid rich because of the lipid rich environment of the epithelial cell environment of the epithelial cell membranes, membranes, the higher lipid solubility the the higher lipid solubility the more the penetrationmore the penetration

Page 6: Ocular pharmacology and toxicology 2.ppt

Factors influencing local Factors influencing local drug penetration into drug penetration into ocular tissueocular tissue

Surfactants:Surfactants: the preservatives used in ocular the preservatives used in ocular preparations preparations alter cell membrane in the alter cell membrane in the corneacornea and increase drug permeability e.g. and increase drug permeability e.g. benzylkonium and thiomersalbenzylkonium and thiomersal

pH:pH: the normal tear pH is 7.4 and if the drug the normal tear pH is 7.4 and if the drug pH is much different, this will cause reflex pH is much different, this will cause reflex tearingtearing

Drug tonicity:Drug tonicity: when an alkaloid drug is put in when an alkaloid drug is put in relatively alkaloid medium, the proportion of relatively alkaloid medium, the proportion of the uncharged form will increase, thus more the uncharged form will increase, thus more penetrationpenetration

Page 7: Ocular pharmacology and toxicology 2.ppt

Eye dropsEye drops

Eye drops- Eye drops- most commonmost common one drop = 50 µlone drop = 50 µl volume of conjunctival cul-de-sac 7-10 µlvolume of conjunctival cul-de-sac 7-10 µl measures to increase drop absorption:measures to increase drop absorption:

-wait 5-10 minutes between drops-wait 5-10 minutes between drops

-compress lacrimal sac-compress lacrimal sac

-keep lids closed for 5 minutes after -keep lids closed for 5 minutes after instillation instillation

Page 8: Ocular pharmacology and toxicology 2.ppt

Ointments Ointments

Increase the contact timeIncrease the contact time of ocular of ocular medication to ocular surface thus medication to ocular surface thus better effectbetter effect

It has the disadvantage of It has the disadvantage of vision vision blurringblurring

The drug has to be high lipid soluble The drug has to be high lipid soluble with some water solubility to have with some water solubility to have the maximum effect as ointmentthe maximum effect as ointment

Page 9: Ocular pharmacology and toxicology 2.ppt

Peri-ocular injectionsPeri-ocular injections

They They reach behind iris-reach behind iris-lens diaphragmlens diaphragm better better than topical applicationthan topical application

E.g. subconjunctival, E.g. subconjunctival, subtenon, peribulbar, or subtenon, peribulbar, or retrobulbarretrobulbar

This route bypass the This route bypass the conjunctival and corneal conjunctival and corneal epithelium which is epithelium which is good for drugs with low good for drugs with low lipid solubilitylipid solubility (e.g. (e.g. penicillins)penicillins)

Also steroid and local Also steroid and local anesthetics can be anesthetics can be applied this wayapplied this way

Page 10: Ocular pharmacology and toxicology 2.ppt

Intraocular injectionsIntraocular injections

Intracameral or Intracameral or intravitrealintravitreal

E.g.E.g.– Intracameral Intracameral

acetylcholine acetylcholine (miochol) during (miochol) during cataract surgerycataract surgery

– Intravitreal antibiotics Intravitreal antibiotics in cases of in cases of endophthalmitisendophthalmitis

– Intravitreal steroid in Intravitreal steroid in macular edemamacular edema

– Intravitreal Anti-VEGF Intravitreal Anti-VEGF for DRfor DR

Page 11: Ocular pharmacology and toxicology 2.ppt

Sustained-release Sustained-release devicesdevices These are devices These are devices

that deliver an that deliver an adequate supply of adequate supply of medication at a medication at a steady-state levelsteady-state level

E.g.E.g.– Ocusert delivering Ocusert delivering

pilocarpinepilocarpine– Timoptic XE Timoptic XE

delivering timololdelivering timolol– Ganciclovir Ganciclovir

sustained-release sustained-release intraocular deviceintraocular device

– Collagen shieldsCollagen shields

Page 12: Ocular pharmacology and toxicology 2.ppt

Systemic drugsSystemic drugs

Oral or IVOral or IV Factor influencing systemic drug Factor influencing systemic drug

penetration into ocular tissue:penetration into ocular tissue:– lipid solubility of the drug:lipid solubility of the drug: more more

penetration with high lipid solubilitypenetration with high lipid solubility– Protein binding:Protein binding: more effect with low more effect with low

protein bindingprotein binding– Eye inflammation:Eye inflammation: more penetration more penetration

with ocular inflammationwith ocular inflammation

Page 13: Ocular pharmacology and toxicology 2.ppt

Ocular Ocular pharmacotherapeuticspharmacotherapeutics

Page 14: Ocular pharmacology and toxicology 2.ppt

Cholinergic agonists Cholinergic agonists

Directly acting agonists:Directly acting agonists:– E.g. pilocarpine, acetylcholine (miochol), carbachol E.g. pilocarpine, acetylcholine (miochol), carbachol

(miostat)(miostat)– Uses:Uses: miosis, glaucoma miosis, glaucoma– Mechanisms:Mechanisms:

Miosis by contraction of the iris sphincter muscle Miosis by contraction of the iris sphincter muscle increases aqueous outflow through the trabecular increases aqueous outflow through the trabecular

meshwork by longitudinal ciliary muscle contractionmeshwork by longitudinal ciliary muscle contraction Accommodation by circular ciliary muscle contractionAccommodation by circular ciliary muscle contraction

– Side effects:Side effects: Local: diminished vision (Local: diminished vision (myopiamyopia), ), headacheheadache, ,

cataract, miotic cysts, and rarely retinal detachmentcataract, miotic cysts, and rarely retinal detachment systemic side effects: lacrimation, salivation, systemic side effects: lacrimation, salivation,

perspiration, bronchial spasm, urinary urgency, perspiration, bronchial spasm, urinary urgency, nausea, vomiting, and diarrheanausea, vomiting, and diarrhea

Page 15: Ocular pharmacology and toxicology 2.ppt

Cholinergic agonistsCholinergic agonists

Indirectly acting (anti-Indirectly acting (anti-cholinesterases) :cholinesterases) :

– More potent with longer duration of More potent with longer duration of actionaction

– Reversible inhibitorsReversible inhibitors e.g. physostigminee.g. physostigmine used in glaucoma and lice infestation used in glaucoma and lice infestation

of lashesof lashes can cause CNS side effectscan cause CNS side effects

Page 16: Ocular pharmacology and toxicology 2.ppt

Cholinergic agonistsCholinergic agonists

Indirectly acting Indirectly acting (anticholinesterases):(anticholinesterases):– Irreversible:Irreversible:

e.g. phospholine e.g. phospholine iodideiodide

Uses:Uses: in in accommodative accommodative esotropiaesotropia

side effects:side effects: iris cyst iris cyst and anterior and anterior subcapsular cataractsubcapsular cataract

C/IC/I in angle closure in angle closure glaucoma, asthma, glaucoma, asthma, ParkinsonismParkinsonism

causes apnea if used causes apnea if used with succinylcholine with succinylcholine or procaineor procaine

Page 17: Ocular pharmacology and toxicology 2.ppt

Cholinergic Cholinergic antagonistsantagonists E.g. tropicamide, cyclopentolate, homatropine, E.g. tropicamide, cyclopentolate, homatropine,

scopolamine, atropinescopolamine, atropine CauseCause mydriasis (by paralyzing the sphincter muscle) mydriasis (by paralyzing the sphincter muscle)

with cycloplegia (by paralyzing the ciliary muscle)with cycloplegia (by paralyzing the ciliary muscle) Uses:Uses: fundoscopy, cycloplegic refraction, anterior fundoscopy, cycloplegic refraction, anterior

uveitisuveitis Side effects:Side effects:

– local: local: allergic reactionallergic reaction, blurred vision, blurred vision– Systemic: nausea, vomiting, pallor, vasomotor collapse, Systemic: nausea, vomiting, pallor, vasomotor collapse,

constipation, urinary retention, and confusionconstipation, urinary retention, and confusion– specially specially in childrenin children they might cause flushing, fever, they might cause flushing, fever,

tachycardia, or delerium tachycardia, or delerium – Treatment by DC or physostigmineTreatment by DC or physostigmine

Page 18: Ocular pharmacology and toxicology 2.ppt

Adrenergic agonistsAdrenergic agonists

Non-selective agonists (Non-selective agonists (αα11, , αα22, , ββ11, , ββ22))– E.g. epinephrine, depevefrin E.g. epinephrine, depevefrin

(pro-drug of epinephrine)(pro-drug of epinephrine)– Uses:Uses: glaucoma glaucoma– Side effects:Side effects: headache, headache,

arrhythmia, increased blood arrhythmia, increased blood pressure, pressure, conjunctival conjunctival adrenochromeadrenochrome, cystoid , cystoid macular edema in aphakic macular edema in aphakic eyeseyes

– C/I in closed angle glaucomaC/I in closed angle glaucoma

Page 19: Ocular pharmacology and toxicology 2.ppt

Adrenergic agonistsAdrenergic agonists

Alpha-1 agonistsAlpha-1 agonists E.g. phenylepherineE.g. phenylepherine Uses:Uses: mydriasis ( mydriasis (withoutwithout cycloplegia), cycloplegia),

decongestantdecongestant Adverse effect:Adverse effect:

– Can cause significant Can cause significant increase in blood increase in blood pressurepressure specially in infant and susceptible specially in infant and susceptible adultsadults

– Rebound congestionRebound congestion– precipitation of acute angle-closure precipitation of acute angle-closure

glaucoma in patients with narrow anglesglaucoma in patients with narrow angles

Page 20: Ocular pharmacology and toxicology 2.ppt

Adrenergic agonistsAdrenergic agonists

Alpha-2 agonistsAlpha-2 agonists– E.g. brimonidine, apraclonidineE.g. brimonidine, apraclonidine– Uses:Uses: glaucoma treatment, prophylaxis against glaucoma treatment, prophylaxis against

IOP spiking after glaucoma laser proceduresIOP spiking after glaucoma laser procedures– Mechanism:Mechanism: decrease aqueous production, and decrease aqueous production, and

increase uveoscleral outflowincrease uveoscleral outflow– Side effects:Side effects:

local: allergic reaction, mydriasis, lid retraction, local: allergic reaction, mydriasis, lid retraction, conjunctival blanchingconjunctival blanching

systemic: oral dryness, headache, fatigue, systemic: oral dryness, headache, fatigue, drowsiness, orthostatic hypotension, vasovagal drowsiness, orthostatic hypotension, vasovagal attacksattacks

– Contraindications:Contraindications: infants, MAO inhibitors users infants, MAO inhibitors users

Page 21: Ocular pharmacology and toxicology 2.ppt

Alpha adrenergic Alpha adrenergic antagonistsantagonists E.g. thymoxamine, dapiprazoleE.g. thymoxamine, dapiprazole Uses:Uses: to reverse pupil dilation to reverse pupil dilation

produced by phenylepherine produced by phenylepherine Not widely usedNot widely used

Page 22: Ocular pharmacology and toxicology 2.ppt

Beta-adrenergic Beta-adrenergic blockersblockers E.g. E.g.

– non-selective: timolol, non-selective: timolol, levobunolol, metipranolol, levobunolol, metipranolol, carteololcarteolol

– selective: betaxolol (beta 1 selective: betaxolol (beta 1 “cardioselective”)“cardioselective”)

Uses:Uses: glaucoma glaucoma Mechanism:Mechanism: reduce the reduce the

formation of aqueous formation of aqueous humor by the ciliary bodyhumor by the ciliary body

Side effects:Side effects: bronchospasmbronchospasm (less with (less with betaxolol), cardiac betaxolol), cardiac impairmentimpairment

Page 23: Ocular pharmacology and toxicology 2.ppt

Carbonic anhydrase Carbonic anhydrase inhibitorsinhibitors E.g. acetazolamide, methazolamide, E.g. acetazolamide, methazolamide,

dichlorphenamide, dorzolamide, brinzolamide.dichlorphenamide, dorzolamide, brinzolamide. Uses:Uses: glaucoma, cystoid macular edema, glaucoma, cystoid macular edema,

pseudotumour cerebripseudotumour cerebri Mechanism:Mechanism: aqueous suppression aqueous suppression Side effects:Side effects: myopia, myopia, parasthesiaparasthesia, anorexia, GI , anorexia, GI

upset, headache, altered taste and smell, Na upset, headache, altered taste and smell, Na and K depletion, metabolic acidosis, renal and K depletion, metabolic acidosis, renal stone, bone marrow suppression “aplastic stone, bone marrow suppression “aplastic anemia”anemia”

Contraindication:Contraindication: sulpha allergy, digitalis sulpha allergy, digitalis users, pregnancyusers, pregnancy

Page 24: Ocular pharmacology and toxicology 2.ppt

Osmotic agentsOsmotic agents

Dehydrate vitreous bodyDehydrate vitreous body which which reduce IOP significantlyreduce IOP significantly

E.G. E.G. – glycerol 50% syrup (cause nausea, glycerol 50% syrup (cause nausea,

hyperglycemia)hyperglycemia)– Mannitol 20% IV (cause fluid Mannitol 20% IV (cause fluid

overload and not used in heart overload and not used in heart failure)failure)

Page 25: Ocular pharmacology and toxicology 2.ppt

Prostaglandin Prostaglandin analoguesanalogues E.g. latanoprost, bimatoprost, travoprost, unoprostoneE.g. latanoprost, bimatoprost, travoprost, unoprostone Uses:Uses: glaucoma glaucoma Mechanism:Mechanism: increase uveoscleral aqueous outflow increase uveoscleral aqueous outflow Side effects:Side effects: darkening of the iris ( darkening of the iris (heterochromia iridisheterochromia iridis), ),

lengthening and thickening of eyelashes, intraocular lengthening and thickening of eyelashes, intraocular inflammation, macular edemainflammation, macular edema

Page 26: Ocular pharmacology and toxicology 2.ppt

Anti-inflammatory

corticosteroid NSAID

Page 27: Ocular pharmacology and toxicology 2.ppt
Page 28: Ocular pharmacology and toxicology 2.ppt

CorticosteroidsCorticosteroids

TopicalTopical– E.g. fluorometholone, remixolone, E.g. fluorometholone, remixolone,

prednisolone, dexamethasone, hydrocortisoneprednisolone, dexamethasone, hydrocortisone– Mechanism:Mechanism: inhibition of arachidonic acid inhibition of arachidonic acid

release from phospholipids by inhibiting release from phospholipids by inhibiting phosphlipase A2phosphlipase A2

– Uses:Uses: postoperatively, anterior uveitis, severe postoperatively, anterior uveitis, severe allergic conjunctivitis, vernal allergic conjunctivitis, vernal keratoconjunctivitis, prevention and keratoconjunctivitis, prevention and suppression of corneal graft rejection, suppression of corneal graft rejection, episcleritis, scleritisepiscleritis, scleritis

– Side effects:Side effects: susceptibility to infectionssusceptibility to infections, , glaucomaglaucoma, , cataractcataract, ptosis, mydriasis, scleral , ptosis, mydriasis, scleral melting, skin atrophymelting, skin atrophy

Page 29: Ocular pharmacology and toxicology 2.ppt

CorticosteroidsCorticosteroids

Systemic:Systemic:– E.g. prednisolone, cortisoneE.g. prednisolone, cortisone– Uses:Uses: posterior uveitis, optic neuritis, posterior uveitis, optic neuritis,

temporal arteritis with anterior ischemic temporal arteritis with anterior ischemic optic neuropathyoptic neuropathy

– Side effects:Side effects: Local: Local: posterior subcapsular cataractposterior subcapsular cataract, glaucoma, , glaucoma,

central serous retinopathycentral serous retinopathy Systemic: suppression of pituitary-adrenal axis, Systemic: suppression of pituitary-adrenal axis,

hyperglycemia, osteoporosis, peptic ulcer, hyperglycemia, osteoporosis, peptic ulcer, psychosispsychosis

Page 30: Ocular pharmacology and toxicology 2.ppt

NSAIDNSAID

E.g. ketorolac, diclofenac, flurbiprofenE.g. ketorolac, diclofenac, flurbiprofen Mechanism:Mechanism: inactivation of cyclo- inactivation of cyclo-

oxygenase oxygenase Uses:Uses: postoperatively, mild allergic postoperatively, mild allergic

conjunctivitis, episcleritis, mild uveitis, conjunctivitis, episcleritis, mild uveitis, cystoid macular edema, cystoid macular edema, preoperatively to prevent miosis preoperatively to prevent miosis during surgeryduring surgery

Side effects:Side effects: stinging stinging

Page 31: Ocular pharmacology and toxicology 2.ppt

Anti-allergics Anti-allergics

Avoidance of allergens, cold compress, lubricationsAvoidance of allergens, cold compress, lubrications AntihistaminesAntihistamines (e.g.pheniramine, levocabastine) (e.g.pheniramine, levocabastine) DecongestantsDecongestants (e.g. naphazoline, phenylepherine, tetrahydrozaline) (e.g. naphazoline, phenylepherine, tetrahydrozaline) Mast cell stabilizersMast cell stabilizers (e.g. cromolyn, lodoxamide, pemirolast, nedocromil, (e.g. cromolyn, lodoxamide, pemirolast, nedocromil,

olopatadine)olopatadine) NSAIDNSAID (e.g. ketorolac) (e.g. ketorolac) SteroidsSteroids (e.g. fluorometholone, remixolone, prednisolone) (e.g. fluorometholone, remixolone, prednisolone) Drug combinationsDrug combinations

Page 32: Ocular pharmacology and toxicology 2.ppt

Antibiotics Antibiotics

PenicillinsPenicillins CephalosporinsCephalosporins SulfonamidesSulfonamides TetracyclinesTetracyclines ChloramphenicolChloramphenicol AminoglycosidesAminoglycosides FluoroquinolonesFluoroquinolones VancomycinVancomycin macrolidesmacrolides

Page 33: Ocular pharmacology and toxicology 2.ppt

Antibiotics Antibiotics

Used Used topicallytopically in prophylaxis in prophylaxis (pre and postoperatively) (pre and postoperatively) and treatment of ocular and treatment of ocular bacterial infections.bacterial infections.

Used Used orallyorally for the treatment for the treatment of preseptal cellulitisof preseptal cellulitise.g. amoxycillin with e.g. amoxycillin with clavulonate, cefaclorclavulonate, cefaclor

Used Used intravenouslyintravenously for the for the treatment of orbital cellulitistreatment of orbital cellulitise.g. gentamicin, e.g. gentamicin, cephalosporin, vancomycin, cephalosporin, vancomycin, flagylflagyl

Can be injected Can be injected intravitrallyintravitrally for the treatment of for the treatment of endophthalmitisendophthalmitis

Page 34: Ocular pharmacology and toxicology 2.ppt

AntibioticsAntibiotics

TrachomaTrachoma can be treated by can be treated by topical and systemic topical and systemic tetracycline or tetracycline or erythromycin, or systemic erythromycin, or systemic azithromycin.azithromycin.

Bacterial keratitisBacterial keratitis (bacterial (bacterial corneal ulcers) can be corneal ulcers) can be treated by topical fortified treated by topical fortified penicillins, cephalosporins, penicillins, cephalosporins, aminoglycosides, aminoglycosides, vancomycin, or vancomycin, or fluoroquinolones.fluoroquinolones.

Bacterial conjunctivitisBacterial conjunctivitis is is usually self limited but usually self limited but topical erythromycin, topical erythromycin, aminoglycosides, aminoglycosides, fluoroquinolones, or fluoroquinolones, or chloramphenicol can be chloramphenicol can be usedused

Page 35: Ocular pharmacology and toxicology 2.ppt

Antifungals Antifungals

Uses:Uses: fungal keratitis, fungal endophthalmitis fungal keratitis, fungal endophthalmitis PolyenesPolyenes

– damage cell membrane of susceptible fungidamage cell membrane of susceptible fungi– e.g. amphotericin B, natamycine.g. amphotericin B, natamycin– side effect: nephrotoxicityside effect: nephrotoxicity

ImidazolesImidazoles– increase fungal cell membrane permeabilityincrease fungal cell membrane permeability– e.g. miconazole, ketoconazolee.g. miconazole, ketoconazole

FlucytocineFlucytocine– act by inhibiting DNA synthesisact by inhibiting DNA synthesis

Page 36: Ocular pharmacology and toxicology 2.ppt

Antivirals Antivirals

AcyclovirAcyclovirinteract with viral interact with viral thymidine kinase thymidine kinase (selective)(selective)used in herpetic keratitisused in herpetic keratitis

TrifluridineTrifluridinemore corneal more corneal penetrationpenetrationcan treat herpetic iritiscan treat herpetic iritis

GanciclovirGanciclovirused intravenously for used intravenously for CMV retinitis CMV retinitis

Page 37: Ocular pharmacology and toxicology 2.ppt

Ocular diagnostic Ocular diagnostic drugsdrugs Fluorescein dyeFluorescein dye

– Available as drops or Available as drops or strips strips

– Uses:Uses: stain corneal stain corneal abrasions, applanation abrasions, applanation tonometry, detecting tonometry, detecting wound leak, NLD wound leak, NLD obstruction, fluorescein obstruction, fluorescein angiographyangiography

– Caution:Caution: stains soft contact lensstains soft contact lens Fluorescein drops can be Fluorescein drops can be

contaminated by contaminated by Pseudomonas sp.Pseudomonas sp.

Page 38: Ocular pharmacology and toxicology 2.ppt

Ocular diagnostic Ocular diagnostic drugsdrugs Rose bengal stainRose bengal stain

– Stains devitalized epitheliumStains devitalized epithelium– Uses:Uses: severe dry eye, herpetic keratitis severe dry eye, herpetic keratitis

Page 39: Ocular pharmacology and toxicology 2.ppt

Local anestheticsLocal anesthetics

topicaltopical– E.g. propacaine, tetracaineE.g. propacaine, tetracaine– Uses:Uses: applanation tonometry, applanation tonometry,

goniscopy, removal of corneal goniscopy, removal of corneal foreign bodies, removal of sutures, foreign bodies, removal of sutures, examination of patients who cannot examination of patients who cannot open eyes because of painopen eyes because of pain

– Adverse effects:Adverse effects: toxic to corneal toxic to corneal epithelium, allergic reaction rarelyepithelium, allergic reaction rarely

Page 40: Ocular pharmacology and toxicology 2.ppt

Local anestheticsLocal anesthetics

Orbital infiltrationOrbital infiltration– peribulbar or retrobulbarperibulbar or retrobulbar– cause cause anesthesiaanesthesia and and akinesiaakinesia

for intraocular surgeryfor intraocular surgery– e.g. lidocaine, bupivacainee.g. lidocaine, bupivacaine

Page 41: Ocular pharmacology and toxicology 2.ppt

Other ocular Other ocular preparationspreparations LubricantsLubricants

– drops or drops or ointmentsointments

– Polyvinyl alcohol, Polyvinyl alcohol, cellulose, cellulose, methylcellulosemethylcellulose

– Preserved or Preserved or preservative freepreservative free

Page 42: Ocular pharmacology and toxicology 2.ppt

Ocular toxicologyOcular toxicology

Page 43: Ocular pharmacology and toxicology 2.ppt

Complications of Complications of topical administrationtopical administration Mechanical injuryMechanical injury from from

the bottle e.g. corneal the bottle e.g. corneal abrasionabrasion

Pigmentation:Pigmentation: epinephrine-epinephrine-adrenochromeadrenochrome

Ocular damage:Ocular damage: e.g. e.g. topical anesthetics, topical anesthetics, benzylkoniumbenzylkonium

Hypersensitivity:Hypersensitivity: e.g. e.g. atropine, neomycin, atropine, neomycin, gentamicingentamicin

Systemic effect:Systemic effect: topical topical phenylephrine can phenylephrine can increase BPincrease BP

Page 44: Ocular pharmacology and toxicology 2.ppt

Amiodarone Amiodarone

A cardiac arrhythmia drugA cardiac arrhythmia drug Causes Causes optic neuropathyoptic neuropathy (mild decreased vision, visual (mild decreased vision, visual

field defects, bilateral optic disc swelling)field defects, bilateral optic disc swelling) Also causes corneal vortex keratopathy (corneal Also causes corneal vortex keratopathy (corneal

verticillata) which is whorl-shaped pigmented deposits verticillata) which is whorl-shaped pigmented deposits in the corneal epitheliumin the corneal epithelium

Page 45: Ocular pharmacology and toxicology 2.ppt

Digitalis Digitalis

A cardiac failure drugA cardiac failure drug Causes Causes chromatopsiachromatopsia (objects (objects

appear yellow) with overdose appear yellow) with overdose

Page 46: Ocular pharmacology and toxicology 2.ppt

Chloroquines Chloroquines

E.g. chloroquine, E.g. chloroquine, hydroxychloroquinehydroxychloroquine

Used in malaria, Used in malaria, rheumatoid arthritis, rheumatoid arthritis, SLESLE

Cause vortex Cause vortex keratopathy (corneal keratopathy (corneal verticillata) which is verticillata) which is usually asymptomatic usually asymptomatic but can present with but can present with glare and photophobiaglare and photophobia

Also cause Also cause retinopathyretinopathy (bull’s eye maculopathy)(bull’s eye maculopathy)

Page 47: Ocular pharmacology and toxicology 2.ppt

Chorpromazine Chorpromazine

A psychiatric drugA psychiatric drug Causes Causes corneal punctatecorneal punctate

epithelial opacitiesepithelial opacities, , lens surface lens surface opacitiesopacities

Rarely symptomaticRarely symptomatic Reversible with drug Reversible with drug

discontinuationdiscontinuation

Page 48: Ocular pharmacology and toxicology 2.ppt

Thioridazine Thioridazine

A psychiatric drugA psychiatric drug Causes a Causes a pigmentary retinopathypigmentary retinopathy

after high dosageafter high dosage

Page 49: Ocular pharmacology and toxicology 2.ppt

Diphenylhydantoin Diphenylhydantoin

An epilepsy drugAn epilepsy drug Causes dosage-related cerebellar-Causes dosage-related cerebellar-

vestibular effects: vestibular effects: – Horizontal Horizontal nystagmusnystagmus in lateral gaze in lateral gaze– DiplopiaDiplopia, , ophthalmoplegiaophthalmoplegia– Vertigo, ataxia Vertigo, ataxia

Reversible with the discontinuation Reversible with the discontinuation of the drugof the drug

Page 50: Ocular pharmacology and toxicology 2.ppt

Topiramate Topiramate

A drug for epilepsyA drug for epilepsy Causes Causes acute angle-closure glaucomaacute angle-closure glaucoma

(acute eye pain, redness, blurred (acute eye pain, redness, blurred vision, haloes).vision, haloes).

Treatment of this type of acute angle-Treatment of this type of acute angle-closure glaucoma is by closure glaucoma is by cycloplegia cycloplegia and topical steroidsand topical steroids (rather than (rather than iridectomy) with the discontinuation iridectomy) with the discontinuation of the drugof the drug

Page 51: Ocular pharmacology and toxicology 2.ppt

Ethambutol Ethambutol

An anti-TB drugAn anti-TB drug Causes a dose-related Causes a dose-related optic optic

neuropathyneuropathy Usually reversible but Usually reversible but

occasionally permanent visual occasionally permanent visual damage might occurdamage might occur

Page 52: Ocular pharmacology and toxicology 2.ppt

Agents that Can Cause Agents that Can Cause Toxic Optic Toxic Optic Neuropathy Neuropathy Methanol Methanol Ethylene glycol (antifreeze) Ethylene glycol (antifreeze) Chloramphenicol Chloramphenicol Isoniazid Isoniazid Ethambutol Ethambutol DigitalisDigitalis Chloroquine Chloroquine Streptomycin Streptomycin Amiodarone Amiodarone Quinine Quinine Vincristine and Vincristine and

methotrexate methotrexate (chemotherapy medicines) (chemotherapy medicines)

Sulfonamides Sulfonamides Melatonin with Zoloft Melatonin with Zoloft

(sertraline, Pfizer) in a (sertraline, Pfizer) in a

high-protein diet high-protein diet Carbon monoxide Carbon monoxide Lead Lead MercuryMercury Thallium (alopecia, skin Thallium (alopecia, skin

rash, severe vision loss) rash, severe vision loss) Malnutrition with vitamin Malnutrition with vitamin

B-1 deficiency B-1 deficiency Pernicious anemia (vitamin Pernicious anemia (vitamin

B-12 malabsorption B-12 malabsorption phenomenon) phenomenon) Radiation (unshielded Radiation (unshielded

exposure to >3,000 rads).exposure to >3,000 rads).

Page 53: Ocular pharmacology and toxicology 2.ppt

HMG-CoA reductase HMG-CoA reductase inhibitors (statins)inhibitors (statins) Cholesterol lowering agentsCholesterol lowering agents E.g. pravastatin, lovastatin, simvastatin, E.g. pravastatin, lovastatin, simvastatin,

fluvastatin, atorvastatin, rosuvastatinfluvastatin, atorvastatin, rosuvastatin Can cause Can cause cataractcataract in high dosages specially if in high dosages specially if

used with erythromycinused with erythromycin

Page 54: Ocular pharmacology and toxicology 2.ppt

Other agentsOther agents

methanolmethanol – optic atrophy and blindness – optic atrophy and blindness Contraceptive pillsContraceptive pills – pseudotumor – pseudotumor

cerebri (papilledema), and dryness (CL cerebri (papilledema), and dryness (CL intolerance)intolerance)

ChloramphenicolChloramphenicol and and streptomycinstreptomycin – – optic atrophyoptic atrophy

Hypervitaminosis AHypervitaminosis A – yellow skin and – yellow skin and conjunctiva, pseudotumor cerebri conjunctiva, pseudotumor cerebri (papilledema), retinal hemorrhage.(papilledema), retinal hemorrhage.

Hypovitaminosis AHypovitaminosis A – night blindness – night blindness (nyctalopia), keratomalacia.(nyctalopia), keratomalacia.

Page 55: Ocular pharmacology and toxicology 2.ppt

Thank youThank you

Any question?